Chimeros' Series B Round

Chimeros raised a round of funding on January 23, 2008. Investors include DFJ Frontier.

Chimeros is developing a biologics approach to enable delivery of polynucleotide therapeutics such as siRNAs. The company's delivery technology, termed Chimerasomes, is based upon protein building blo…

Articles about Chimeros' Series B Round: